Your session is about to expire
← Back to Search
Metoprolol Tartrate for Heart Disease (ORION Trial)
ORION Trial Summary
This trial will test if metoprolol can reduce heart complications in patients with CAD.
ORION Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.ORION Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the FDA's stance on Metoprolol Tartrate?
"There is some evidence of efficacy and multiple reports of safety, so Metoprolol Tartrate was given a score of 3."
What precedent exists for using Metoprolol Tartrate therapeutically?
"As of today, there are 22 ongoing clinical trials studying the effects of Metoprolol Tartrate. 4 of these studies have reached Phase 3. The majority of research locations for Metoprolol Tartrate are situated in Orlando, Florida; though, altogether, 146 different centres are running active Metoprolol Tartrate trials."
How is Metoprolol Tartrate most often used?
"Metoprolol Tartrate can help patients who suffer from angina pectoris, atrial fibrillation, and other conditions that cause instability in the cardiovascular system."
How many enrollees does this research project have at present?
"This particular trial is no longer seeking new participants. The study was first posted on December 1st, 2016 and received its latest update on April 20th, 2018. However, if you are interested in other trials, there are currently 340 studies actively recruiting patients with heart diseases and 22 trials for Metoprolol Tartrate that have open enrolment."
Are patients currently being enrolled in this trial?
"This study isn't enrolling at the moment. The listing was first posted on December 1st, 2016 and edited most recently on April 20th, 2018. However, there are presently 340 trials actively looking for participants with heart diseases and 22 trials for Metoprolol Tartrate that need patients."
Share this study with friends
Copy Link
Messenger